Prevalence, comorbidity, and risk factors for functional bowel symptoms: A population-based survey in Northern Norway

Scandinavian Journal of Gastroenterology

Volumn 47, Issue 11, 2012, Pages 1274-1282

  Breckan, Ragnar K ^a,c   Asfeldt, Anne Mette ^b   Straume, Bjørn ^c   Florholmen, Jon ^b,c   Paulssen, Eyvind J ^b,c  

^a NORDLAND HOSPITAL   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Comorbidity; Helicobacter pylori; Irritable bowel syndrome; Population

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ABDOMINAL DISCOMFORT; ABDOMINAL DISTENSION; ABDOMINAL PAIN; ABDOMINAL SURGERY; ADULT; ARTICLE; COMORBIDITY; CONSTIPATION; CONTROLLED STUDY; COPING BEHAVIOR; DEFECATION URGENCY; DEPRESSION; DIARRHEA; DIZZINESS; FECES ANALYSIS; FEMALE; FLATULENCE; FUNCTIONAL BOWEL SYMPTOM; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL SYMPTOM RATING SCALE; HEADACHE; HEALTH SURVEY; HEART PALPITATION; HELICOBACTER INFECTION; HUMAN; HUNGER; MALE; MUSCULOSKELETAL DISEASE; NORWAY; OBESITY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PSYCHOMETRY; QUESTIONNAIRE; RISK FACTOR; SEX DIFFERENCE; SLEEP DISORDER;

ABDOMINAL PAIN; ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COMORBIDITY; CONSTIPATION; DEPRESSION; DIARRHEA; DIZZINESS; DYSSOMNIAS; FEMALE; FLATULENCE; HEADACHE; HEALTH STATUS; HEALTH SURVEYS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; MUSCULOSKELETAL PAIN; NORWAY; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SEX FACTORS; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84867556798     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2012.688215     Document Type: Article

References (61)

1. Drossmann DA, Morris CB, Schneck S, Hu YJB, Norton NJ, Norton WF, et al. International survey of patients with IBS. Symptom features and their severity, health status, treatments and risk taking to achieve clinical benefit. J Clin Gastroenterol 2009;43:541-50.
2. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Marin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130:1480-91.
3. Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis for the irritable bowel. BMJ 1978;2:653-4. (Pubitemid 9004104)
4. Thompson WG, Longstreth G, Drossmann DA, Heaton K, Irvine EJ, Muller-Lisner S. Functional bowel disorders and Functional abdominal pain. In Drossmann DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, editors. Rome II: the functional gastrointestinal disorders. 2nd ed. Mclean, VA, USA: Degnon Associates; 2000. pp 351-432.
5. Whitehead WE, Drossmann DA. Validation of symptom-based diagnostic criteria for irritable bowel syndrome: a critical review. Am J Gastroenterol 2010;105:814-20.
6. Bolling-Sternevald E, Aro P, Ronkainen J, Storskrubb T, Talley NJ, Junghard O, et al. Do gastrointestinal symptoms fluctuate in the short-term perspective? The Kalixanda study. Dig Dis 2008;26:256-63. (Pubitemid 351667810)
7. Talley NJ. Irritable bowel syndrome: definition, diagnosis and epidemiology. Baillières Clin Gastroenterol 1999;13: 371-84. (Pubitemid 29537350)
8. Hillilä MT, Färrkkilä NJ, Färkkilä MA. Societal costs for irritable bowel syndrome - a population based study. Scand J Gastroenterol 2010;45:582-91.
9. Rajilic-Stojanovic M, Biagi E, Heilig HGHJ, Kajander K, Kekkonen RA, Tims S, et al. Global and deep moecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 2011;141:1792-801.
10. Ghoshal UC, Ranjan P. Post-infectious irritable bowel syndrome: the past, the presence and the future. J Gastroenterol Hepatol 2011;26:94-101.
11. Dupont HL. Gastrointestinal infections and the development of irritable bowel syndrome. Curr Opin Infect Dis 2011;24: 503-8.
12. Dinan TG, Cryan J, Shanahan F, Keeling PWN, Quigley EMM. IBS: an epigenetic perspective. Nat Rev Gastroenterol Hepatol 2011;7:465-71.
13. Fukudo S, Kanazawa M. Gene, environment, and brain-gut interactions in irritable bowel syndrome. J Gastroenterol Hepatol 2011;26:110-15.
14. Öhman L, Simrén M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol 2010;7:163-73.
15. rd, Zinsmeister AR, Talley NJ, Fett SL, Melton LJ. Risk factors for irritable bowel syndrome: role of analgetics and food sensitivities. Am J Gastroenterol 2000; 95:157-65. (Pubitemid 30041552)
16. Gibson PR. Food intolerance in functional bowel disorders. J Gastroenterol Hepatol 2011;26:128-31.
17. Chang L, Heitkemper MM. Gender differences in irritable bowel syndrome. Gastroenterology 2002;123:1686-701. (Pubitemid 35231668)
18. Adeyemo MA, Spiegel BMR, Chang L. Meta-analysis: do irritable bowel syndrome symptoms vary between men and women? Aliment Pharmacol Ther 2010;32:738-55.
19. Miller V, Whitaker K, Morris JA, Whorwell PJ. Gender and irritable bowel syndrome: the male connection. J Clin Gastroenterol 2004;38:558-60. (Pubitemid 38955411)
20. Olafsdottir LB, Gudjonsson H, Jonsdottir HH, Thjodleifsson B. Natural history of functional dyspepsia: a 10-year population-based study. Digestion 2010;81:53-61.
21. Aro P, Talley NJ, Johansson S-E, Bolling-Sternevald E, Storskrubb T, Ronkainen J. Functional dyspepsia impairs quality of life in the adult population. Aliment Pharmacol Ther 2011;33:1215-24.
22. Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA. Migraine, fibromyalgia, and depression among people with IBS: a prevalence study. BMC Gastroenterol 2006;6:26.
23. Mykletun A, Jacka F, Williams L, Pascoe J, Henry M, Nicholson GC, et al. Prevalence of mood and anxiety disorder in self reported irritable bowel syndrome (IBS). An epidemiological population based study of women. BMC Gastroenterol 2010;10:88.
24. Go MF. Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 2002; 16(Suppl 1):3-15. (Pubitemid 41759561)
25. Su YC, Wang WM, Wang SY, Lu SN, Chen LT, Wu DC, et al. The association between Helicobacter pylori infection and functional dyspepsia in patients with irritable bowel syndrome. Am J Gastroenterol 2000;95:1900-5.
26. Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P. Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior. Am J Gastroenterol 2008;103:1229-39. (Pubitemid 351677964)
27. rd, Talley NJ, Nelson DK, Haruma K, Weaver AL, Zinsmeister AR, et al. Helicobacter pylori and dyspepsia: a population-based study of the organism and host. Am J Gastroenterol 2000;95:1906-13. (Pubitemid 30629285)
28. Kawamura A, Adachi K, Takashima T, Yuki M, Ono M, Kinoshita Y. Prevalence of irritable bowel syndrome and its relationship with Helicobacter pylori infection in a Japanese population. Am J Gastroenterol 2000;96:1946.
29. Agréus L, Engstrand L, Svärdsudd K, Nyrén O, Tibblin G. Helicobacter pylori seropositivity among Swedish adults with and without abdominal symptoms. A population-based epidemiologic study. Scand J Gastroenterol 1995;30:752-7.
30. Bernersen B, Johnsen R, Straume B, Burhol PG, Jenssen TG, Stakkevold PA. Towards a true prevalence of peptic ulcer: the Sørreisa gastrointestinal disorder study. Gut 1990;31:989-92. (Pubitemid 20295930)
31. Asfeldt AM, Straume B, Steigen SE, Løchen M-L, Florholmen J, Bernersen B, et al. Changes in the prevalence of dyspepsia and Helicobacter pylori infection after 17 years: the Sørreisa gastrointestinal disorder study. Eur J Epidemiol 2008;23:625-33.
32. Breckan RK, Paulssen EJ, Asfeldt AM, Mortensen L, Straume B, Florholmen J. The impact of body mass index and Helicobacter pylori infection on gastro-oesophageal reflux symptoms: a population-based study in Northern Norway. Scand J Gastroenterol 2009;44:1060-6.
33. Svedlund J, Sjödin I, Dotevall G. GSRS - a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988; 33:129-34. (Pubitemid 18054672)
34. Wiklund IK, Fullerton S, Hawkey CJ, Jones RH, Longstreth GF, Mayer EA, et al. An irritable bowel syndrome-specific symptom questionnaire: development and validation. Scand J Gastroenterol 2003;38:947-54. (Pubitemid 37153623)
35. Altman DG, Macin D, Bryant TN, Gardner MJ editors. Statistics with confidence. 2nd ed. London, UK: BMJ Publishing Group; 2000.
36. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series 2001;31 Geneva, Switzerland: World Health Organization.
37. Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Aliment Pharmacol Ther 2003;17:643-50. (Pubitemid 36418887)
38. Vandvik PO, Lydersen S, Farup PG. Prevalence, comorbidity and impact of irritable bowel syndrome in Norway. Scand J Gastroenterol 2006;41:650-6. (Pubitemid 43995005)
39. Chang JY, Talley NJ. An update on irritable bowel syndrome. Curr Opin Gastroenterol 2011;27:72-8.
40. Mayer EA. Irritable bowel syndrome. N Engl J Med 2008; 358:1692-9.
41. Henderson PK, DiPalma JA. Diagnosing irritable bowel syndrome; a changing clinical paradigm. South Med J 2011;104:195-9.
42. Liu J, Hou X. A review of the irritable bowel syndrome investigation on epidemiology, pathogenesis and pathophysiology in China. J Gastroenterol Hepatol 2011;26:88-93.
43. Bommelaer G, Poynard T, Le Pen C, Gaudin A-F, Maurel F, Priol G, et al. Prevalence of irritable bowel syndrome (IBS) and variablility of diagnostic criteria. Gastroenterol Clin Biol 2004;28:554-61. (Pubitemid 38917487)
44. Morton LM, Cahill J, Hartge P. Reporting participation in epidemiologic studies: a survey of practice. Am J Epidemiol 2005;163:197-203.
45. Houghton LA, Jackson NA, Whorwell PJ, Morris J. Do male sex hormones protect from irritable bowel syndrome? Am J Gastroenterol 2000;95:2296-300.
46. Cain KC, Jarrett ME, Burr RL, Rosen S, Hertig VL, Heitkemper MM. Gender differences in gastrointestinal, psychological, and somatic symptoms in irritable bowel syndrome. Dig Dis Sci 2009;54:1542-9.
47. Simsek I. Irritable bowel syndrome and other functional gastrointestinal disorders. J Clin Gastroenterol 2011;45: S86-8.
48. Yarandi SS, Nasseri-Moghaddam S, Mostajabi P, Malekzadeh R. Overlapping gastroesophageal reflux disease and irritable bowel syndrome: increased dysfunctional symptoms. World J Gastroenterol 2010;16:1232-8.
49. Gasiorowska A, Poh CH, Fass R. Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS) - is it one disease or an overlap of two disorders? Dig Dis Sci 2009; 54:1829-34.
50. Mönnikes H, Heading RC, Schmitt H, Doerfler H. Influence of irritable bowel syndrome on treatment outcome in gastroesophageal reflux disease. World J Gastroenterol 2011;17: 3235-41.
51. Wu JC, Lai LH, Chow DK, Wong GL, Sung JJ, Chan FK. Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease. Neurogastroenterol Motil 2011;23:155-60.
52. Hillilä MT, Hämäläinen J, Heikkinen ME, Färkkilä MA. Gastrointestinal complaints among subjects with depressive symptoms in the general population. Aliment Pharmacol Ther 2008;28:648-54.
53. Ladabaum U, Boyd E, Zhao WK, Mannalithara A, Sharabidze A, Singh G, et al. Diagnosis, comorbidities and management of irritable bowel syndrome in patients in a large health maintenance organization. Clin Gastroenterol Hepatol 2012;10:37-45.
54. Johansson PA, Farup C, Bracco A, Vandvik PO. How does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice. BMC Gastroenterol 2010;10:31.
55. Lyra A, Rinttilä T, Nikkilä J, Krogius-Kurikka L, Kajander K, Malinen E, et al. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA phylotype quantification. World J Gastroenterol 2009;15:5936-45.
56. Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med 2011;364:22-32.
57. Morken MH, Valeur J, Norin E, Midtvedt T, Nysæter G, Berstad A. Antibiotic or bacterial therapy in post-giardiasis irritable bowel syndrome. Scand J Gastroenterol 2009;44: 1296-303.
58. Kerckhoffs APM, Akkermans LM, de Smet MBM, Besselinkm MGH, Hietbrink F, Bartelink IH, et al. Intestinal permeability in irritable bowel syndrome patients: effects of NSAIDs. Dig Dis Sci 2010;55:716-23.
59. rd. Is irritable bowel syndrome more likely to be persistent in those with relatives who suffer from gastrointestinal symptoms? A population-based study at three time points. Aliment Pharmacol Ther 2003; 17:1389-97. (Pubitemid 36774146)
60. Malinen E, Rinttilä T, Kajander K, Mättö J, Kassinen A, Krogius L, et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005;100:373-82. (Pubitemid 40314522)
61. Zhao Y, Wang R, Ma X, Yan X, Man X, Gao L, et al. Dyspepsia and irritable bowel syndrome in China: a population-based endoscopy study of prevalence and impact. Aliment Pharmacol Ther 2010;32:562-72.